{
    "organizations": [],
    "uuid": "286e1f788e89c0698def9664d7a89fd7419ce96c",
    "author": "",
    "url": "https://www.reuters.com/article/brief-azurrx-biopharma-receives-2-mln-in/brief-azurrx-biopharma-receives-2-mln-in-proceeds-from-exercise-of-warrants-idUSFWN1PB1GD",
    "ord_in_thread": 0,
    "title": "BRIEF-AzurRx Biopharma receives $2 mln in proceeds from exercise of warrants",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 16 (Reuters) - Azurrx Biopharma Inc:\n* AZURRX BIOPHARMA RECEIVES $2 MILLION IN PROCEEDS FROM EXERCISE OF WARRANTS\n* AZURRX BIOPHARMA - ‍HAS RECEIVED PROCEEDS OF APPROXIMATELY $2.04 MILLION THROUGH EXERCISE OF A TOTAL OF 851,987 OUTSTANDING COMMON STOCK PURCHASE WARRANTS​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-17T06:19:00.000+02:00",
    "crawled": "2018-01-17T06:37:42.019+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "azurrx",
        "biopharma",
        "inc",
        "azurrx",
        "biopharma",
        "receives",
        "million",
        "proceeds",
        "exercise",
        "warrant",
        "azurrx",
        "biopharma",
        "received",
        "proceeds",
        "approximately",
        "million",
        "exercise",
        "total",
        "outstanding",
        "common",
        "stock",
        "purchase",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}